EA200100153A1 - Совместное назначение ингибиторов асат и ммр для лечения атеросклеротических поражений - Google Patents

Совместное назначение ингибиторов асат и ммр для лечения атеросклеротических поражений

Info

Publication number
EA200100153A1
EA200100153A1 EA200100153A EA200100153A EA200100153A1 EA 200100153 A1 EA200100153 A1 EA 200100153A1 EA 200100153 A EA200100153 A EA 200100153A EA 200100153 A EA200100153 A EA 200100153A EA 200100153 A1 EA200100153 A1 EA 200100153A1
Authority
EA
Eurasian Patent Office
Prior art keywords
asat
atherosclerotic
defects
treatment
mmp inhibitors
Prior art date
Application number
EA200100153A
Other languages
English (en)
Inventor
Томас Майкель Эндру Бокан
Original Assignee
Варнер-Ламберт Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Варнер-Ламберт Компани filed Critical Варнер-Ламберт Компани
Publication of EA200100153A1 publication Critical patent/EA200100153A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Предмет данного изобретения составляет совместное назначение веществ, ингибирующих АСАТ и ММР, для понижения компонентов атеросклеротического поражения, связанных с макрофагами и с клетками гладких мышц, которое приводит к ослаблению экспансии существующих поражений и развития новых поражений, предупреждает отрыв бляшек и способствует регрессии поражений у млекопитающих.Отчет о международном поиске был опубликован 2000.05.18.
EA200100153A 1998-07-21 1999-06-18 Совместное назначение ингибиторов асат и ммр для лечения атеросклеротических поражений EA200100153A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9363998P 1998-07-21 1998-07-21
PCT/US1999/013948 WO2000004892A2 (en) 1998-07-21 1999-06-18 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions

Publications (1)

Publication Number Publication Date
EA200100153A1 true EA200100153A1 (ru) 2001-08-27

Family

ID=22239992

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100153A EA200100153A1 (ru) 1998-07-21 1999-06-18 Совместное назначение ингибиторов асат и ммр для лечения атеросклеротических поражений

Country Status (25)

Country Link
EP (1) EP1098662A2 (ru)
JP (1) JP2002521328A (ru)
KR (1) KR20010083134A (ru)
CN (1) CN1310629A (ru)
AP (1) AP2001002035A0 (ru)
AU (1) AU4701799A (ru)
BG (1) BG105162A (ru)
BR (1) BR9912296A (ru)
CA (1) CA2335062A1 (ru)
CZ (1) CZ2001126A3 (ru)
EA (1) EA200100153A1 (ru)
EE (1) EE200100046A (ru)
HR (1) HRP20010055A2 (ru)
HU (1) HUP0102880A3 (ru)
ID (1) ID30030A (ru)
IL (1) IL140982A0 (ru)
IS (1) IS5809A (ru)
NO (1) NO20010291D0 (ru)
OA (1) OA11584A (ru)
PL (1) PL346011A1 (ru)
SK (1) SK502001A3 (ru)
TR (1) TR200100205T2 (ru)
WO (1) WO2000004892A2 (ru)
YU (1) YU3501A (ru)
ZA (1) ZA200100294B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2382676A1 (en) * 1999-11-05 2001-05-17 Warner-Lambert Company Prevention of plaque rupture by acat inhibitors
GT200000203A (es) 1999-12-01 2002-05-24 Compuestos, composiciones y metodos para estimular el crecimiento y elongacion de neuronas.
JP2003534239A (ja) * 1999-12-17 2003-11-18 ヴァージコア・インコーポレーテッド 新規なスクシナート化合物、組成物、並びに使用及び調製方法
AU8254101A (en) * 2000-09-01 2002-03-22 Sankyo Co Medicinal compositions
GB0100761D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
JP4606027B2 (ja) * 2002-04-03 2011-01-05 トポターゲット ユーケー リミテッド Ｈｄａｃ阻害剤としてのピペラジン結合を有するカルバミン酸化合物
JP4617449B2 (ja) * 2002-07-11 2011-01-26 ヴィキュロン ファーマシューティカルズ インコーポレイテッド 抗菌活性を有するｎ−ヒドロキシアミド誘導体
WO2011092284A1 (en) * 2010-01-29 2011-08-04 Euroscreen S.A. Novel amino acid derivatives and their use as gpr43 receptor modulators
CN104211695B (zh) * 2013-06-04 2017-04-12 中国医学科学院医药生物技术研究所 一组胺甲酰基苯磺酰类化合物的用途
EP3244883A1 (en) * 2015-01-15 2017-11-22 Biocant - Associação De Transferência De Tecnologia Treatment of hutchinson-gilford progeria syndrome and diseases related to vascular ageing
CN106831697B (zh) * 2017-03-15 2019-11-05 深圳市康道生物有限公司 川榛有效提取成分及其在防治动脉粥样硬化中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
PT841913E (pt) * 1995-08-04 2003-06-30 Warner Lambert Co Utilizacao de derivados sulfamico acil sulfonamidas ou sulfonil carbamatos para a producao de um medicamento para reduzir os niveis de lipoproteinas
CA2253342A1 (en) * 1996-05-17 1997-11-27 Warner-Lambert Company Biphenylsulfonamide matrix metalloproteinase inhibitors
KR20000068414A (ko) * 1996-09-04 2000-11-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 매트릭스 메탈로프로테이나제 억제제 및 그의 치료적 용도

Also Published As

Publication number Publication date
BG105162A (en) 2001-12-29
EE200100046A (et) 2002-06-17
HUP0102880A3 (en) 2002-11-28
TR200100205T2 (tr) 2001-05-21
IS5809A (is) 2001-01-12
WO2000004892A3 (en) 2000-05-18
ID30030A (id) 2001-11-01
NO20010291L (no) 2001-01-18
CA2335062A1 (en) 2000-02-03
SK502001A3 (en) 2002-06-04
BR9912296A (pt) 2001-04-17
WO2000004892A2 (en) 2000-02-03
HUP0102880A2 (en) 2002-06-29
CN1310629A (zh) 2001-08-29
NO20010291D0 (no) 2001-01-18
YU3501A (sh) 2005-06-10
ZA200100294B (en) 2002-01-10
AU4701799A (en) 2000-02-14
OA11584A (en) 2004-07-20
HRP20010055A2 (en) 2002-04-30
JP2002521328A (ja) 2002-07-16
PL346011A1 (en) 2002-01-14
CZ2001126A3 (cs) 2002-01-16
EP1098662A2 (en) 2001-05-16
IL140982A0 (en) 2002-02-10
KR20010083134A (ko) 2001-08-31
AP2001002035A0 (en) 2001-03-31

Similar Documents

Publication Publication Date Title
EA200100153A1 (ru) Совместное назначение ингибиторов асат и ммр для лечения атеросклеротических поражений
DE602004025030D1 (de) System für fussgelenksarthroplastie
ITBO990430A0 (it) Mezzo di fissazione femorale dei tendini di semitendinoso e del gracil e per la ricostruzione del legamento crociato anteriore .
EA199900384A1 (ru) Устройство для очистки межзубного промежутка и способ его изготовления
ATE369848T1 (de) Verwendung von d-serine oder d-alanine zur behandlung von schizophrenie
NO975747D0 (no) Peptidylheterocykler for anvendelse ved behandling av trombin-relaterte mangler
EA200200208A1 (ru) Синергитическая композиция
DE69721554D1 (de) Wässrige reinigungs- und desinfektionsmittel mit niedrigem rückstand für harte oberflächen
ES2178157T3 (es) Tratamiento de arritmias mediante la inhibicion de una proteina quinasa multifuncional dependiente de calcio/calmodulina.
ID18047A (id) Proses pembuatan bahan antara untuk florfenikol
AU5624699A (en) Use of 5ht-6 antagonists
DE69725052D1 (de) Verbindungsstift für mehrteiliges orthopädisches Implantat
EA200000536A1 (ru) Применение комбинации ингибитора конвертирующего фермента и диуретика для лечения нарушений микроциркуляции
ID22650A (id) Penggunaan penghambat-penghambat lipase usus lambung
ID27544A (id) Agonis dan antagonis muskarinat
DE69917663D1 (de) 2-methyl-thieno-benzodiazepin-formulierung
FR2607004B1 (fr) Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
ID22060A (id) Senyawa-senyawa 2-imidazolinilaminobenzoksazol berguna sebagai agonis adrenoseptor
ES2168816T3 (es) Cemento de inyeccion que contiene inhibidores de la corrosion.
ATE261434T1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
NO995914L (no) Fremgangsmåte for å påvise risiko for trombose
FR2744621B1 (fr) Determination des tunnels femoral et tibial pour la reconstruction isometrique du ligament croise anterieur
NO20004920D0 (no) Anvendelse av proteaseinhibitorer for behandling av hudskader
BR9714376A (pt) Antagonistas de somatostatina